SenesTech to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Thursday, March 16, 2023

Rhea-AI Summary

SenesTech, Inc. (NASDAQ: SNES) is set to release its financial results for the fourth quarter and fiscal year 2022 after market close on March 16, 2023. A conference call will follow at 5:00 pm ET to discuss the outcomes. The company's proprietary technology, ContraPest, is focused on managing rodent populations through fertility control rather than extermination. This unique approach aligns with sustainable pest management practices. Investors can join the conference call via telephone or through a live webcast available on SenesTech's Investor Relations website.

Positive

• Upcoming financial results for Q4 and FY 2022 may provide insights into company performance and future outlook.
• ContraPest, the company's product, is the only EPA-registered contraceptive for rats, offering a sustainable pest management solution.

Negative

• None.

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET

PHOENIX, March 8, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its fourth quarter and fiscal year 2022, ended December 31, 2022, after the market close on Thursday, March 16, 2023. The Company has scheduled a conference call that same day, Thursday, March 16, 2023, at 5:00 pm ET, to review the results.

Fourth Quarter and Fiscal Year 2022 Conference Call Details

Date and Time: Thursday, March 16, 2023, at 5:00 pm ET

Call-in Information: Interested parties can access the conference call by dialing (844) 308-3351 or (412) 317-5407.

Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company's website at https://app.webinar.net/5v2Mg0EOqmV or http://senestech.investorroom.com/.

Replay: A teleconference replay of the call will be available for seven days at (877) 344-7529 or (412) 317-0088, replay access code 2860260. A webcast replay will be available in the Investor Relations section of the Company's website at http://senestech.investorroom.com/ for 90 days. 

About SenesTech
We are "The Pest Control Difference" for the 21st century. We are rodent fertility control specialists fueled by our passion to create a healthy environment by virtually eliminating rodent pest populations. We keep an inescapable truth in mind: 2 rats and their descendants can be responsible for the birth of up to 15,000 pups in a year. We invented ContraPest , the only U.S. EPA-registered contraceptive for male and female rats. ContraPest fits seamlessly into all integrated pest management programs, greatly improving the overall goal of effective rat management. We strive for clean cities, efficient businesses, and happy households – with a product that was designed to be effective and sustainable without killing rats. At SenesTech , we don't just eliminate rats. We make a better world.

For more information visit https://senestech.com/ and https://contrapeststore.com.

Safe Harbor Statement The foregoing paragraphs contain forward-looking statements that involve estimates, assumptions, risks and uncertainties. Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. "Forward-looking statements" may be preceded by words such as "may," "future," "plan" or "planned," "will," "should," "expected," "anticipates," "continue," "eventually," "believes," or "projected." Forward-looking statements include statements concerning the potential impact and effects of the COVID-19 pandemic on the Company's business, results of operations and financial performance; any measures the Company has and may take in response to COVID-19 and any expectations the Company may have with respect thereto; the Company's strategy and target marketing and markets; continuing the Company's vision; expected benefits of the Company's initiatives and continuation of those initiatives; deployment of the Company's product; the continuation or expansion of the use of ContraPest; demand for ContraPest; the Company's expectation regarding costs, expenses and cash and continuing its cost improvement plan; future financial results; and the Company's execution of its strategic business plan.

CONTACT: 

Investor: Robert Blum, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-fourth-quarter-and-fiscal-year-2022-financial-results-on-thursday-march-16-2023-301766285.html

SOURCE SenesTech, Inc.

FAQ

When will SenesTech report its fourth quarter and fiscal year 2022 financial results?

SenesTech will report its financial results after market close on March 16, 2023.

What is the significance of the conference call scheduled for March 16, 2023?

The conference call will discuss the financial results for the fourth quarter and fiscal year 2022, providing insights into the company's performance.

How can investors participate in the SenesTech conference call?

Investors can participate by dialing the call-in number or accessing the live webcast via the Investor Relations section of the SenesTech website.